Faeth Therapeutics, Inc. Capital Expenditures Incurred but Not yet Paid
Faeth Therapeutics, Inc. (FTH) reported Capital Expenditures Incurred but Not yet Paid of $11.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2023-05-09
- Faeth Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2022-03-31 was $11.00K, a 26.67% decline year-over-year.
- Faeth Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2021-09-30 was $47.00K.
- Faeth Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2021-06-30 was $41.00K, a 94.69% decline year-over-year.
- Faeth Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2021-03-31 was $15.00K, a 200.00% increase year-over-year.
- Faeth Therapeutics, Inc. capital expenditures incurred but not yet paid for fiscal 2020 was $204.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2022-03-31 | $11.00K 10-Q · filed 2023-05-09 | |||
| 2021-09-30 | $47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $88.00K derived: sum of 2 quarters · filed 2022-11-08 | $103.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $56.00K 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $15.00K 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $204.00K 10-K · filed 2022-03-15 | |||
| 2020-06-30 | $772.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $777.00K 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | $5.00K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |